EMA Recharges Role In Non-EU Drug Approvals
Agency Wants More Firms To Use ‘EU-Medicines4all’ Scheme
The EMA’s process for assessing medicines for use in non-EU countries is being beefed up after a review showed the mechanism had several flaws that made it unattractive to many companies.
